SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts

Purpose: To investigate the immunoprevalence of SALL4-derived peptides in healthy volunteers and cancer patients. Experimental Design: A multistep approach including prediction algorithms was used to design in silico SALL4-derived peptides theoretically able to bind on common HLA-DR and HLA-A/B mole...

Full description

Bibliographic Details
Main Authors: Marie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, Laura Boullerot, Stefano Kim, Marine Jary, Jeanne Galaine, Emilie Picard, Christophe Ferrand, Thierry Nguyen, Fabrice Larosa, Olivier Adotévi, Yann Godet, Christophe Borg
Format: Article
Language:English
Published: Taylor & Francis Group 2018-04-01
Series:OncoImmunology
Subjects:
cancer
immunotherapy
sall4
tumor antigen
t lymphocytes
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1412030

Internet

http://dx.doi.org/10.1080/2162402X.2017.1412030

Similar Items